Comparison
Bacopa Monnieri vs Tribulus Terrestris
Bacopa Monnieri
Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. The active bacosides increase dendritic branching in the hippocampus over weeks of dosing. Effects are slow but durable; expect 8–12 weeks before full effect.
Tribulus Terrestris
Mediterranean and Indian herb traditionally used for libido and athletic performance. Evidence is mixed; the testosterone-raising claims are mostly unsupported.
| Field | Bacopa Monnieri | Tribulus Terrestris |
|---|---|---|
| Category | adaptogen | adaptogen |
| Dose range | 300–600mg | 250–750mg |
| Half-life | 4h | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 540 | 320 |
The comparison in plain English
Auto-generated from dataBacopa Monnieri and Tribulus Terrestris are both in the adaptogen category respectively. Bacopa Monnieri Ayurvedic herb (Bacopa monnieri) with the strongest natural-nootropic evidence base for memory acquisition and retention. Tribulus Terrestris Mediterranean and Indian herb traditionally used for libido and athletic performance.
Bottom line
Bacopa Monnieri (evidence A, safety 5/5) has a weaker evidence base than Tribulus Terrestris (evidence B, safety 4/5). Bacopa Monnieri has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Bacopa Monnieri if
Bacopa Monnieri is the better fit when your goal aligns with its mechanism (Active bacosides A and B increase dendritic branching in the CA3 region of the hippocampus, the structural change that underlies improved memory consolidation) and the dose range (300–600mg) suits your protocol. Half-life is 4h.
Choose Tribulus Terrestris if
Tribulus Terrestris is the better fit when your goal aligns with its mechanism (Contains steroidal saponins (protodioscin and related compounds) that have been hypothesised to modulate testosterone, LH, and DHEA — but multiple well-designed RCTs have failed to confirm testosterone elevation in healthy young men) and the dose range (250–750mg) suits your protocol. Half-life is —h.